MB Grožio terapijos studija Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
8,790 |
- |
1,015 |
964 |
- |
39.17 |
10.97 |
7,367 |
215 |
5,174 |
5,916 |
2023 |
---|
9,223 |
- |
525 |
499 |
- |
42.20 |
5.41 |
7,756 |
88 |
1,547 |
6,784 |
2024 |
---|
5,814 |
- |
-2,288 |
-2,288 |
- |
75.56 |
-39.35 |
5,468 |
12 |
413 |
5,067 |
Register and
explore Okredo data2024 |
---|
5,814 |
- |
-2,288 |
-2,288 |
- |
75.56 |
-39.35 |
5,468 |
12 |
413 |
5,067 |
Register and
explore Okredo data2024
Turnover (€)
5,814 €-37 % *
Sales per employee (€)
-Profit before tax (€)
-2,288 €-536 % *
Net Profit (€)
-2,288 €-559 % *
Profit per employee (€)
-Total profitability (%)
75.56 %79.05 % *
Net profitability (%)
-39.35 %-827.36 % *
Equity (€)
5,468 €-30 % *
Amounts Payable And Liabilities (€)
12 €-86 % *
Non-current Assets (€)
413 €-73 % *
CurrentAssets (€)
5,067 €-25 % *